NasdaqGS - Nasdaq Real Time Price USD
uniQure N.V. (QURE)
17.27
+0.66
+(3.97%)
At close: June 6 at 4:00:00 PM EDT
16.82
-0.45
(-2.58%)
After hours: June 6 at 7:54:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 10 |
| Avg. Estimate | -0.77 | -0.72 | -3 | -2.53 |
| Low Estimate | -0.94 | -0.97 | -3.99 | -3 |
| High Estimate | -0.6 | -0.18 | -2.25 | -1.72 |
| Year Ago EPS | -1.08 | -0.84 | -4.73 | -3 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 13 | 13 |
| Avg. Estimate | 5.03M | 9.42M | 26.67M | 63.11M |
| Low Estimate | -- | -- | 1.42M | 14.87M |
| High Estimate | 8.88M | 51.12M | 97.93M | 163.43M |
| Year Ago Sales | 10.32M | 2.1M | 26.06M | 26.67M |
| Sales Growth (year/est) | -51.21% | 348.44% | 2.34% | 136.63% |
Earnings History
| Currency in EUR | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.16 | -0.93 | -0.52 | -0.93 |
| EPS Actual | -1.08 | -0.84 | -1.44 | -0.73 |
| Difference | 0.08 | 0.09 | -0.92 | 0.21 |
| Surprise % | 7.13% | 9.77% | -178.82% | 22.13% |
EPS Trend
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.77 | -0.72 | -3 | -2.53 |
| 7 Days Ago | -0.77 | -0.72 | -3.02 | -2.55 |
| 30 Days Ago | -0.95 | -0.88 | -3.61 | -2.96 |
| 60 Days Ago | -0.98 | -0.91 | -3.71 | -2.73 |
| 90 Days Ago | -0.97 | -0.88 | -3.64 | -2.73 |
EPS Revisions
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 2 | 2 |
| Up Last 30 Days | 7 | 7 | 7 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 3 | 2 | 3 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| QURE | 28.57% | 14.45% | 36.56% | 15.57% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 5/30/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/29/2025 |
| Reiterates | Guggenheim: Buy to Buy | 5/12/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/12/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/6/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/21/2025 |
Related Tickers
RGNX REGENXBIO Inc.
9.61
+14.95%
TRVI Trevi Therapeutics, Inc.
7.06
+4.75%
ANAB AnaptysBio, Inc.
23.70
+12.11%
SLDB Solid Biosciences Inc.
4.5400
+6.82%
NKTR Nektar Therapeutics
0.6660
-1.30%
LXEO Lexeo Therapeutics, Inc.
3.8800
+18.65%
SRRK Scholar Rock Holding Corporation
34.23
-0.06%
URGN UroGen Pharma Ltd.
7.37
+43.39%
RARE Ultragenyx Pharmaceutical Inc.
37.17
+0.69%
KURA Kura Oncology, Inc.
6.73
+2.44%